COVID-19 and multisystem inflammatory syndrome in children and adolescents

Area of Science:

• Pediatric infectious diseases
• Public health
• Immunology

Background:

• Global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to reports of multisystem inflammatory conditions in children and adolescents.
• The precise association between multisystem inflammatory syndrome in children (MIS-C) and COVID-19 remains unclear.

Purpose of the Study:

• To review the epidemiology, etiology, clinical manifestations, and treatment strategies for MIS-C associated with COVID-19 in pediatric populations.
• To explore potential pathophysiological mechanisms underlying COVID-19-induced inflammation and subsequent organ damage in severely ill children.
• To highlight the need for a standardized case definition and treatment protocol for MIS-C, and to inform future therapeutic and vaccine development.

Main Methods:

• Comprehensive literature review of published studies on MIS-C and COVID-19.
• Analysis of epidemiological data, clinical case reports, and treatment outcomes.
• Discussion of proposed pathophysiological pathways based on current scientific understanding.

Main Results:

• Increasing global reports of MIS-C in children and adolescents following SARS-CoV-2 outbreaks.
• Identification of diverse clinical presentations and potential organ involvement in affected pediatric patients.
• Exploration of inflammatory pathways contributing to severe illness and organ damage.

Conclusions:

• Evidence supports a link between SARS-CoV-2 infection and MIS-C in pediatric populations.
• A clear case definition and standardized treatment protocols are urgently needed for MIS-C.
• Further research into pathophysiology is crucial for developing effective interventions and potential vaccines.